Physician profile
Robert Mcgee
NPI 1457345456
$3,438.35
in general payments reported to CMS, 2019-2025
16 companies · $633 in 2025
The $633 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $328 · 2021: $241 · 2022: $547 · 2023: $617 · 2024: $547 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,797.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,038.57 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Zimvie INC. | $419.25 | 2022-2025 | |
| Insmed, INC. | $255.38 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $162.72 | 2019-2025 | Opsumit, Uptravi |
| Ceribell, INC. | $132.43 | 2025 | Pocket Eeg Device |
| Pfizer INC. | $99.70 | 2024 | |
| Inari Medical, INC. | $63.67 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $57.43 | 2019 | |
| Intuitive Surgical, INC. | $55.15 | 2022 | |
| Genentech USA, INC. | $53.08 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $24.73 | 2024 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.35 | 2019 | |
| United Therapeutics Corporation | $15.79 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.63 | 2023 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $13.88 | 2023 | Dupixent |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.